<rss version="2.0"><channel><title>BioSpace.com News</title><link>http://www.biospace.com</link><generator>BioSpace RSS Generator</generator><lastBuildDate>Tue, 18 Jun 2013 20:58:51 GMT</lastBuildDate><ttl>20</ttl><image><url>http://rss.biospace.com/images/BSPLogo.gif</url><title>BioSpace.com</title><link>http://www.BioSpace.com/news.aspx?SectionId=1</link></image><copyright>Copyright (C) 2011</copyright><item><title>Oculus Innovative Sciences, Inc. Announces Confidential Submission of Draft Registration Statement for Initial Public Offering to Securities and Exchange Commission by Its Subsidiary  </title><link>http://www.globenewswire.com/news-release/2013/05/28/550106/10034114/en/Oculus-Announces-Confidential-Submission-of-Draft-Registration-Statement-for-Initial-Public-Offering-to-Securities-and-Exchange-Commission-by-Its-Subsidiary-Ruthigen-Inc.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;PETALUMA, Calif., May 28, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (the "Company") (Nasdaq:OCLS) a global healthcare company that designs, manufactures and markets prescription and non-prescription...</description><pubDate>Tue, 28 May 2013 12:00:00 AM GMT</pubDate></item><item><title>NanoString Technologies Inc. Maneuvers in Line for $86 Million IPO  </title><link>http://www.biospace.com/news_story.aspx?StoryID=297377&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;font size"3"&gt;&lt;b&gt;NanoString Technologies Files Registration Statement with the Securities and Exchange Commission for an Initial Public Offering&lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;SEATTLE--(BUSINESS WIRE)--May 20, 201...</description><pubDate>Tue, 21 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Bausch &amp; Lomb Files IPO of Up to $100 Million  </title><link>http://www.rttnews.com/2082477/bausch-lomb-files-ipo-of-up-to-100-mln.aspx?type=corp</link><description>ROCHESTER, N.Y.&lt;/span&gt;, &lt;span class"xn-chron"&gt;March 22, 2013&lt;/span&gt; /PRNewswire/ -- Bausch  Lomb, the global eye health company, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC), through its holding company WP Prism, relating to the proposed initial public offering of its common stock.  The number of shares to be offered...</description><pubDate>Mon, 25 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Diagnostics Instrument Maker AutoGenomics Files Again for IPO  </title><link>http://www.xconomy.com/san-diego/2012/10/01/diagnostics-instrument-maker-autogenomics-files-again-for-ipo/</link><description>AutoGenomics, a Vista, CA-based company that specializes in molecular diagnostics systems, has filed for a $65 million Initial Public Offering (IPO), according to a recent regulatory filing. The company, founded in 1999, plans to trade on Nasdaq under the ticker symbol AGMX. The filing marks the second IPO attempt for the diagnostic instrument company. AutoGenomics previously filed for an $86.3 million...</description><pubDate>Tue, 02 Oct 2012 12:00:00 AM GMT</pubDate></item><item><title>Singulex, Inc. Files for a $86 Million IPO  </title><link>http://www.mercurynews.com/business/ci_21657419/singulex-files-ipo-hopes-raise-86-3-million</link><description>San Francisco Business Times by Ron Leuty, Reporter&lt;/p&gt;&lt;p&gt;Alameda diagnostic test developer Singulex Inc. filed for an $86.25 million initial public offering Friday, promising a test to measure signs of heart disease at previously undetectable levels.&lt;/p&gt;&lt;p&gt;Using the Jumpstart Our Business Startups, or JOBS, Act to qualify as an "emerging growth company," 15-year-old Singulex said in a filing...</description><pubDate>Mon, 01 Oct 2012 12:00:00 AM GMT</pubDate></item><item><title>Globus Medical, Inc. Files for $100 Million IPO  </title><link>http://www.reuters.com/article/2012/03/29/us-globusmedical-idUSBRE82S0GQ20120329</link><description>Medical device company Globus Medical Inc filed with regulators on Thursday to raise up to $100 million in an initial public offering of common stock. The Audubon, Pennsylvania-based company told the U.S. Securities and Exchange Commission in a preliminary prospectus that BofA Merrill Lynch, Goldman Sachs, Piper Jaffray and Leerink Swann were lead underwriters to the IPO. The company makes and commercializes...</description><pubDate>Thu, 29 Mar 2012 12:00:00 AM GMT</pubDate></item><item><title>Seattle Biotech Atossa Genetics, Inc. Files for $6 Million IPO  </title><link>http://www.renaissancecapital.com/ipohome/news/Biotech-Atossa-Genetics-files-for-$6-million-US-IPO-11051.html</link><description>Puget Sound Business Journal by Valerie Bauman, Staff Writer &lt;/p&gt;&lt;p&gt;Seattle-based biotech Atossa Genetics plans to issue 1 million shares of stock in a $6 million U.S. initial public offering, according to SEC filings.&lt;/p&gt;&lt;p&gt;Atossa develops diagnostic tests and treatments for breast cancer, including an FDA-approved mammary aspirate specimen cytology test (MASCT) system that can quickly and...</description><pubDate>Wed, 15 Feb 2012 12:00:00 AM GMT</pubDate></item><item><title>Obesity Med Device Maker GI Dynamics Files IPO Down Under
  </title><link>http://www.xconomy.com/boston/2011/08/04/gi-dynamics-and-exa-file-for-ipos-in-weight-loss-devices-automotive-software/</link><description>Lexington, Mass.-based medical device company GI Dynamics   GI Dynamics Latest from The Business Journals Gastric bypass alternative gets EU nodHuman Capital: People on the Move Aug. 19Medtronic bets on New England startups Follow this company  is preparing an IPO in Australia that could raise up to $95 million Australian ($100.4 million US), according to a regulatory filing.&lt;/p&gt;&lt;p&gt;GI Dynamics...</description><pubDate>Thu, 04 Aug 2011 12:00:00 AM GMT</pubDate></item><item><title>Zeltiq  Files for $115 Million IPO  </title><link>http://www.xconomy.com/san-francisco/2011/07/14/coolsculptor-zeltiq-plans-ipo/</link><description>Zeltiq Aesthetics filed for a $115 million initial public stock offering Wednesday, hoping its noninvasive process to reduce love handles and other unwanted fat will be embraced by Wall Street. Pleasanton-based Zeltiq didn't disclose the terms of the offering, including the price per share or the number of shares that will comprise the IPO. The timing of the offering wasn't disclosed. Founded in ...</description><pubDate>Mon, 18 Jul 2011 12:00:00 AM GMT</pubDate></item><item><title>Lucid Files IPO For Up To $28.8M To Repay Debt, Expand Business  </title><link>http://online.wsj.com/article/BT-CO-20110415-713739.html</link><description>WSJ -- Lucid Inc. filed plans to sell up to $28.8 million of common stock in an initial public offering, as the medical-device maker seeks to raise money to repay debt and build its global research and sales.</description><pubDate>Tue, 19 Apr 2011 12:00:00 AM GMT</pubDate></item><item><title>Brainsway Files $30M IPO  </title><link>http://www.streetinsider.com/IPOs/Brainsway+Ltd.+%28BRIN%29+Files+$30M+IPO/6422376.html</link><description>Street Insider -- Brainsway Limited (Nasdaq: BRIN) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Ordinary Shares. The proposed maximum offering amount is $30 million. Brainsway filed to list on the Nasdaq Capital Market under the ticker "BRIN."</description><pubDate>Tue, 12 Apr 2011 12:00:00 AM GMT</pubDate></item><item><title>BG Medicine Goes Public at $7 Per Share  </title><link>http://www.xconomy.com/boston/2011/02/04/bg-medicine-goes-public-at-7-per-share/</link><description>Xconomy -- Waltham, MA-based BG Medicine (NASDAQ: BGMD) started trading publicly today at $7 per share. After indicating earlier in the week that it had planned to offer 4.75 million shares in its initial public offering, the diagnostics company sold 5 million shares. Lazard Capital Markets acted as sole book-running manager for the deal, and underwriters will have  the 30-day option to purchase an...</description><pubDate>Mon, 07 Feb 2011 12:00:00 AM GMT</pubDate></item><item><title>Urologix Reports Results for Fiscal Year 2011 Second Quarter  </title><link>http://www.globenewswire.com/newsroom/news.html?d=211833</link><description>MINNEAPOLIS, Jan. 25, 2011 (GLOBE NEWSWIRE) -- Urologix, Inc. (Nasdaq:ULGX), the manufacturer and marketer of minimally invasive Cooled ThermoTherapy (CTT), the durable and effective in-office treatment for patients suffering from benign prostatic hyperplasia (BPH), today reported financial results for the second quarter of its fiscal year 2011 that ended December 31, 2010.</description><pubDate>Wed, 26 Jan 2011 12:00:00 AM GMT</pubDate></item><item><title>Genetics Instrument Maker Fluidigm Corporation Refiles for $86 million IPO  </title><link /><description>SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of Fluidigm's common stock. Fluidigm develops, manufactures and markets microfluidic systems for growth markets in the life science and agricultural biotechnology, or...</description><pubDate>Mon, 06 Dec 2010 12:00:00 AM GMT</pubDate></item><item><title>SurgiVision, Inc. Postpones $18 Million IPO Because Of Market Conditions  </title><link>http://www.renaissancecapital.com/ipohome/news/SurgiVision-postpones-$18-million-IPO-8415.html</link><description>Wall Street Journal --  SurgiVision Inc.'s initial public offering has been postponed because of market conditions, an underwriter said Monday. </description><pubDate>Wed, 01 Sep 2010 12:00:00 AM GMT</pubDate></item><item><title>REVA Medical Inc. Files for $63 Million IPO in Australia  </title><link>http://www.socaltech.com/reva_medical_looks_to_australia_for_ipo/s-0030440.html</link><description>REVA Medical Inc., a San Diego-based developer of bioresorbable stents to treat arterial disease, has filed for a $63 million IPO in Australia. Inteq Ltd. is serving as lead underwriter.&lt;p&gt;&lt;/p&gt;The company has raised around $57 million in VC funding, from groups like Domain Partners (21.6$ pre-IPO stake), Cerberus Capital Management (11.4%), Brookside Capital (11%) and Group Outcome (5.6%). www.teamreva...</description><pubDate>Tue, 17 Aug 2010 12:00:00 AM GMT</pubDate></item><item><title>Electromed, Inc. Announces Pricing of Initial Public Offering  </title><link>http://www.medcitynews.com/2010/08/not-looking-good-for-electromed-initial-public-offering/</link><description>NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (Nasdaq:ELMD - News), which is a leader in developing innovative airway clearance therapy products for use by patients with compromised pulmonary function, today announced pricing of its initial public offering of 1,700,000 shares of common stock at a price of $4.00 per share, before underwriting discounts and commissions.&lt;p&gt;&lt;/p&gt;The offering is...</description><pubDate>Fri, 13 Aug 2010 12:00:00 AM GMT</pubDate></item><item><title>Medical-Device Maker China Kanghui Files For $75M US IPO  </title><link>http://www.renaissancecapital.com/ipohome/news/Orthopedic-implant-provider-China-Kanghui-files-for-a-$75-million-IPO-8296.html</link><description>Wall Street Journal --  China Kanghui Holdings, a medical-device maker, registered for an initial public offering of American depositary shares of up to $75 million.</description><pubDate>Fri, 30 Jul 2010 12:00:00 AM GMT</pubDate></item><item><title>CARMAT SAS Sets $89.81 Million IPO to Fund Artificial Heart on July 13  </title><link>http://www.reuters.com/article/idCNLDE66629220100707?rpc=44</link><description>PARIS, July 7 (Reuters) - French artificial heart developer Carmat, which counts EADS (EAD.PA) amongst its shareholders, has set the date of its initial public offering for July 13 as it seeks extra funds to bring its product to market.</description><pubDate>Thu, 08 Jul 2010 12:00:00 AM GMT</pubDate></item><item><title>BioHorizons Files for $100 Million IPO  </title><link>http://www.forbes.com/feeds/ap/2010/06/24/business-health-care-us-biohorizons-ipo-filing_7716336.html</link><description>Forbes -- Dental implant maker BioHorizons Inc. on Wednesday filed a registration statement for an initial public offering worth up to $100 million.</description><pubDate>Thu, 24 Jun 2010 12:00:00 AM GMT</pubDate></item><item><title>Tornier B.V. Files for up to $205 Million IPO  </title><link>http://www.reuters.com/article/idCNSGE6570E820100608?rpc=44</link><description>Reuters -- Medical device company Tornier B.V. filed with the U.S. regulators on Tuesday to raise up to $205 million in an initial public offering.  The Netherlands-based company said it will use the net proceeds to repay debt. It may use the proceeds to acquire other businesses, products or technologies, the company added.</description><pubDate>Tue, 08 Jun 2010 12:00:00 AM GMT</pubDate></item><item><title>Migraine Patch Maker NuPathe Inc. Files for $86.3M IPO  </title><link>http://www.streetinsider.com/IPOs/NuPathe+Inc.+%28PATH%29+Files+$86.25M+IPO/5637564.html</link><description>Businessweek -- Specialty pharmaceutical company NuPathe Inc., which is developing a patch that treats migraines, on Friday filed for an initial public offering valued at up to $86.3 million.</description><pubDate>Mon, 17 May 2010 12:00:00 AM GMT</pubDate></item><item><title>Aurora Diagnostics Inc. Files For Up To $150 Mln IPO  </title><link>http://www.reuters.com/article/idCNSGE63T0F020100430?rpc=44</link><description>Wall Street Journal --  Disease-diagnostic company Aurora Diagnostics Inc. announced plans to sell up to $150 million of stock in an initial public offering. </description><pubDate>Fri, 30 Apr 2010 12:00:00 AM GMT</pubDate></item><item><title>Kips Bay Medical to Raise up to $57.5 Million Via IPO  </title><link>http://www.reuters.com/article/idCNSGE6370GJ20100408?rpc=44</link><description>Reuters -- Medical device company Kips Bay Medical Inc filed with U.S. securities regulators on Friday to raise up to $57.5 million in an initial public offering of common stock.</description><pubDate>Thu, 08 Apr 2010 12:00:00 AM GMT</pubDate></item><item><title>GenMark Diagnostics Files Registration Statement for Initial Public Offering  </title><link>http://www.biospace.com/news_story.aspx?StoryID=174454&amp;full=1</link><description>PASADENA, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. announced today that it has filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock. GenMark is a Delaware corporation and, in connection with the offering, will become the parent holding company of Osmetech, plc.&lt;/p&gt;&lt;p&gt;Piper Jaffray &amp; Co. will act as the sole...</description><pubDate>Fri, 19 Mar 2010 12:00:00 AM GMT</pubDate></item><item><title>DynaVox Technologies Files for $125 Million IPO  </title><link>http://www.pehub.com/59951/dynavox-files-for-125-million-ipo/</link><description>&lt;!-- AddThis Button BEGIN --&gt;&lt;script type"text/javascript"&gt;var addthis_pub"bdwyer";&lt;/script&gt;&lt;a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"&gt;&lt;img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...</description><pubDate>Wed, 06 Jan 2010 12:00:00 AM GMT</pubDate></item><item><title>Osmetech Plc Announces Initial Public Offering of American Depositary Shares  </title><link>http://www.biospace.com/news_story.aspx?StoryID=109479&amp;full=1</link><description>PASADENA, Calif.--(BUSINESS WIRE)--Osmetech plc, a molecular diagnostics company, (LSE:OMH - News) (proposed NASDAQ Global Market Symbol: OSMH) today announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of 5,500,000 American Depositary Shares (ADSs) (representing 192,500,000 ordinary shares...</description><pubDate>Fri, 12 Sep 2008 12:00:00 AM GMT</pubDate></item><item><title>Medical Device Firm TherOx Files for $100 Million IPO  </title><link>http://www.reuters.com/article/marketsNews/idINN0440894220080904?rpc=44</link><description>&lt;p&gt;    IRVINE, Calif., Sept. 4 /PRNewswire/ -- TherOx, Inc. announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of shares of its common stock.&lt;/p&gt;&lt;p&gt;    Citigroup Global Markets Inc. and UBS Investment Bank are acting as joint book-running managers for the offering with Cowen and Company...</description><pubDate>Fri, 05 Sep 2008 12:00:00 AM GMT</pubDate></item><item><title>Illumina, Inc. Announces 3.5 Million Share Public Offering  </title><link>http://www.biospace.com/news_story.aspx?StoryID=105635&amp;full=1</link><description>SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it has filed a preliminary prospectus supplement to a shelf registration statement with the Securities and Exchange Commission relating to a proposed public offering of 3,500,000 shares of its common stock. The underwriter will be granted the right to purchase up to an additional 525,000 shares of common stock. All of the...</description><pubDate>Mon, 04 Aug 2008 12:00:00 AM GMT</pubDate></item><item><title>Select Medical Files $100M IPO  </title><link>http://www.streetinsider.com/IPOs/Select+Medical+Holdings+(SLC)+Files+$100M+IPO/3848787.html</link><description>It's not the best time for an initial public offering, but if you need cash fast, it is one way to get it. Select Medical Holdings, the operator of outpatient rehabilitation centers and acute care hospitals, filed plans with the U.S. Securities and Exchange Commission on Friday for an IPO underwritten by Wall Street heavyweights Morgan Stanley, Merrill Lynch and Goldman Sachs.</description><pubDate>Wed, 30 Jul 2008 12:00:00 AM GMT</pubDate></item><item><title>ZONARE Medical Systems, Inc. Files Registration Statement for Initial Public Offering  </title><link>http://www.biospace.com/news_story.aspx?StoryID=102308&amp;full=1</link><description>MOUNTAIN VIEW, CA--(MARKET WIRE)--Jul 3, 2008 -- ZONARE Medical Systems, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission for a proposed initial public offering of shares of its common stock. Copies of the registration statement on Form S-1 can be accessed through the SEC's website at www.sec.gov.&lt;/p&gt;&lt;p&gt;Citi and Piper Jaffray...</description><pubDate>Thu, 03 Jul 2008 12:00:00 AM GMT</pubDate></item><item><title>Acclarent, Inc. Files For Initial Public Offering  </title><link>http://biz.yahoo.com/ap/080606/acclarent_ipo.html?.v=1</link><description>NEW YORK (AP) -- Medical technology company Acclarent Inc. filed Friday with the Securities and Exchange Commission for an initial public offering of common stock.  The number and expected price range of shares to be offered were not disclosed. The Menlo Park, Calif.-based company plans to use proceeds from the offering for sales, marketing and training initiatives; research and development activities...</description><pubDate>Fri, 06 Jun 2008 12:00:00 AM GMT</pubDate></item><item><title>BioTrove, Inc. Announces Filing of Registration Statement for Initial Public Offering  </title><link /><description>WOBURN, Mass.--(BUSINESS WIRE)--BioTrove, Inc. today announced that it has filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock. Piper Jaffray &amp; Co. and Lazard Capital Markets are acting as joint book-running managers and Robert W. Baird &amp; Co. is acting as co-manager.&lt;/p&gt;&lt;p&gt;A copy of the written prospectus relating...</description><pubDate>Tue, 01 Apr 2008 12:00:00 AM GMT</pubDate></item><item><title>Salient Surgical Technologies Files for $86.3M IPO  </title><link>http://www.reuters.com/article/marketsNews/idUKWNAS467220080313?rpc=44</link><description>DOVER, N.H.--(BUSINESS WIRE)--Salient Surgical Technologies, Inc. announced today that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock. All shares of the common stock to be sold in the offering will be offered by Salient Surgical Technologies.&lt;/p&gt;&lt;p&gt;Bear, Stearns &amp; Co. Inc. and Piper Jaffray ...</description><pubDate>Thu, 13 Mar 2008 12:00:00 AM GMT</pubDate></item></channel></rss>